HIPAA rules expect the utmost in patient privacy, even online.
Medical blogs may threaten patient privacy, according to a new study published online in the Journal of General Internal Medicine. The Robert Wood Johnson Foundation and researchers at the University of Pennsylvania examined content from 271 medical blogs and found that more than half contained enough information to reveal the author’s identity.
Although researchers say that overt violations of patient privacy are rare, “anonymous” medical bloggers who provide information about their location, subspecialty or other personal details inadvertently reveal their identity to patients, colleagues or other members of the public. In some cases, patients described in these blogs may be able to identify themselves.
MHE Editorial Advisor Joel V. Brill, MD, chief medical officer of Predictive Health LLC believes that managed care executives can help by developing a policy to address appropriate corporate policies regarding official and unofficial posts.
“Companies may wish to monitor what is being said about you and what your employees are blogging about,” Dr. Brill says. “Although this [research] addresses privacy issues by physicians, it is just as important from a corporate perspective, especially if your employees are inadvertently providing information. Once it’s out on the Internet, it’s accessible to all.”
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Mental Health Comorbidities Affect Uptravi Prescribing for PAH
October 23rd 2024New real-world data suggest that physicians are cautious about prescribing the prostacyclin-receptor agonist Uptravi (selexipag) to pulmonary arterial hypertension (PAH) patients with mental health conditions when evidence suggests that it is best to take a proactive approach to treating PAH.
Read More